674 related articles for article (PubMed ID: 27955666)
21. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
Munro J; O'Sullivan D; Andrews C; Arana A; Mortimer A; Kerwin R
Br J Psychiatry; 1999 Dec; 175():576-80. PubMed ID: 10789357
[TBL] [Abstract][Full Text] [Related]
22. [Ten years of clinical experience with clozapine about 170 patients].
Levoyer D; Martinet JP; Badiche A; Millet B
Encephale; 2004; 30(3):285-95. PubMed ID: 15235527
[TBL] [Abstract][Full Text] [Related]
23. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
24. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
26. [Granulocytopenia while using clozapine: continuing or stopping treatment].
Bogers JP
Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
[TBL] [Abstract][Full Text] [Related]
27. Increase in white cell and neutrophil counts during the first eighteen weeks of treatment with clozapine in patients admitted to a long-term psychiatric care inpatient unit.
Capllonch A; de Pablo S; de la Torre A; Morales I
Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(2):94-100. PubMed ID: 27156787
[TBL] [Abstract][Full Text] [Related]
28. Morning pseudoneutropenia during clozapine treatment.
Esposito D; Aouillé J; Rouillon F; Limosin F
World J Biol Psychiatry; 2003 Oct; 4(4):192-4. PubMed ID: 14608591
[TBL] [Abstract][Full Text] [Related]
29. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
30. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
[TBL] [Abstract][Full Text] [Related]
31. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
[TBL] [Abstract][Full Text] [Related]
32. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
33. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
34. Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.
van der Weide K; Loovers H; Pondman K; Bogers J; van der Straaten T; Langemeijer E; Cohen D; Commandeur J; van der Weide J
Pharmacogenomics J; 2017 Oct; 17(5):471-478. PubMed ID: 27168101
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
36. Clozapine-associated neutropenic enterocolitis.
Beck DA; Miller DD
Ann Clin Psychiatry; 1994 Sep; 6(3):185-8. PubMed ID: 7881499
[TBL] [Abstract][Full Text] [Related]
37. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
38. Neutropenia induced by second generation antipsychotics: a prospective investigation.
Rettenbacher MA; Hofer A; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050
[TBL] [Abstract][Full Text] [Related]
39. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
40. Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland.
Ingimarsson O; MacCabe JH; Sigurdsson E
Nord J Psychiatry; 2018 Oct; 72(7):497-500. PubMed ID: 30348045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
